Beginning March 30, 2026, facilities may optionally report weekly data on therapeutics administered to residents for COVID-19, influenza, and RSV using the NHSN Respiratory Pathogens and Vaccination (RPV) Module.
Reporting for the therapeutics data fields is optional. More information is available in the following resources:
- RPV Module Resident Summary Guidance Document
The NHSN team will host two training sessions in late April 2026 to review RPV Module updates including new therapeutics reporting capabilities. Registration links and additional information will be sent closer to the event.